-+ 0.00%
-+ 0.00%
-+ 0.00%

Design Therapeutics Q1 EPS $(0.31) Misses $(0.28) Estimate

Benzinga·05/07/2025 20:46:53
Listen to the news
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year.